666125-10MG Display Image

Urea Transporter B Inhibitor; UTBinh-14

Code: 666125-10MG D2-231

Biochem/physiol Actions

Reversible: yes

Cell permeable: yes

Primary Targeturea transporter B

General description

A cell-permeable tri...


read more

Your Price
£208.11 10MG
Discontinued
£249.73 inc. VAT

Biochem/physiol Actions

Reversible: yes

Cell permeable: yes

Primary Targeturea transporter B

General description

A cell-permeable triazolothienopyrimidine compound that acts as a reversible urea transporter B (UT-B)-selective inhibitor (IC50 = 10.3 and 25.1 nM against urea influx using human and mouse erythrocytes, respectively) by targeting a UT-B intracellular site in a urea-competitive manner, exhibiting little effect toward UT-A1, UT-A3, AQP1, CFTR, or TMEM16A channel activities and no cytotoxicity in MDCK cultures (100% viability after 24 h 10 µM inhibitor treatment). Shown to effectively decrease maximum urinary concentration (2.3- and 3.7-fold of basal [urea], respectively, with or without inhibitor; 300 µg/300 µl/mouse i.p.) and increase urination volume (236 vs.109 µl/4h, respectively, with or without inhibitor) from antidiuretic dDAVP- (1 µg/kg; administered 1 h after inhibitor) treated wild-type, but not UT-B-/-, mice in vivo. Despite its short half-life (t1/2 = 2.8 min) in in vitro rat hepatic microsomes stability tests, an average inhibitor concentration of 390 µM in blood can be reached in mice even 6 h after a single i.p. dose of 200 µl per animal.

A cell-permeable triazolothienopyrimidine compound that acts as a reversible urea transporter B-selective inhibitor (IC50 = 10.3 and 25.1 nM against urea influx using human and mouse erythrocytes, respectively) by targeting a UT-B intracellular site in a urea-competitive manner, exhibiting little effect toward UT-A1, UT-A3, AQP1, CFTR, or TMEM16A channel activities. Shown to effectively decrease maximum urinary concentration and increase urination volume from antidiuretic dDAVP-treated wild-type, but not UT-B-/-, mice (300 µg/300 µl/mouse i.p.) in vivo.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Other Notes

Anderson, M.O., et al. 2012. J. Med. Chem.55, 5942.Yao, C., et al. 2012. J. Am. Soc. Nephrol.23, 1210.

Packaging

Packaged under inert gas

10 mg in Glass bottle

Warning

Toxicity: Standard Handling (A)

assay≥98% (HPLC)
colorwhite
formpowder
manufacturer/tradenameCalbiochem®
Quality Level100
shipped inambient
solubilityDMSO: 100 mg/mL
storage conditionprotect from light, OK to freeze
storage temp.2-8°C
Cas Number892742-76-6
This product has met the following criteria: